In fetal calf serum fractions analysed by mass spectrometry, thymosin beta4 was observed among low-abundance peptides.
In plain wordsIn lab tests of calf serum, mass spectrometry detected thymosin beta4 among low-abundance peptides.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- Not applicableDetection of thymosin beta4 in serum fractions
- Study
n: not reported in source
fetal calf serum- Outcome group
- Receptor activity and mechanism · Pharmacology
Source sentences
apparent low-abundance peptides associated with cancer biology from proteins such as insulin-like growth factor II, thymosin beta4 and beta9, plasminogen, coagulation factors, and extracellular matrix protein 1 were observed.
1 context sentence(design, population, supporting numbers)
Matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization (ESI) hybrid quadrupole time-of-flight (Qq-TOF) were used to analyze the precipitated and extracted endogenous peptides from fetal calf serum.
In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).